Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 5/20 | 0.35 |
| ▸ | DRD5 | P21918 | 5/20 | 0.35 |
| ▸ | DRD2 | P14416 | 4/20 | 0.35 |
| ▸ | DRD4 | P21917 | 3/20 | 0.35 |
| ▸ | DRD3 | P35462 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9948370 | 0.74 | ALOX15 (0.36) | CYP1A2DRD1DRD5DRD2DRD4 | |
| SCHEMBL22081972 | 0.71 | CYP1A2 (0.62) | CYP1A2DRD1DRD5DRD2DRD4 | |
| SCHEMBL1525601 | 0.71 | — | — | |
| SCHEMBL29881712 | 0.71 | — | — | |
| SCHEMBL109650 | 0.71 | CYP1A2 (0.62) | CYP1A2DRD1DRD5DRD2DRD4 | |
| SCHEMBL6837855 | 0.70 | METAP2 (0.53) | MAOACYP3A4TSHRHSD17B10METAP2 | |
| SCHEMBL30940280 | 0.70 | METAP2 (0.53) | MAOACYP3A4TSHRHSD17B10METAP2 | |
| SCHEMBL10976988 | 0.69 | TSHR (0.60) | CYP1A2DRD1DRD5DRD2DRD4 | |
| SCHEMBL29136589 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL4314909 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8334384-B2 | Process for preparing tetrahydrotetraazapentacenes and derivatives | XEROX CORPORATION (US) | 2012-12-18 | — | — | US | disclosed |
| US-8283659-B2 | Tetrahydrotetraazapentacenes in thin-film transistors | XEROX CORPORATION (US) | 2012-10-09 | — | — | US | disclosed |
| US-20120161108-A1 | TETRAHYDROTETRAAZAPENTACENES IN THIN-FILM TRANSISTORS | XEROX CORPORATION (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120165529-A1 | PROCESS FOR PREPARING TETRAHYDROTETRAAZAPENTACENES AND DERIVATIVES | XEROX CORPORATION (US) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161108-A1 | TETRAHYDROTETRAAZAPENTACENES IN THIN-FILM TRANSISTORS | CYP4Z1, TCF4, TERT | CYP1A2 265/4885DRD1 1465/4885DRD5 1873/4885 |
| US-20120165529-A1 | PROCESS FOR PREPARING TETRAHYDROTETRAAZAPENTACENES AND DERIVATIVES | DHPS, TBXA2R, DHRS9 | CYP1A2 20/4885DRD1 255/4885DRD5 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.